仁和堂医药下属药店因医保违规被立案，曾多次计划上市

Core Viewpoint - The Inner Mongolia Hohhot Medical Security Bureau has reported violations by Inner Mongolia Renhe Tang Pharmaceutical Chain Co., Ltd., leading to the termination of medical insurance agreements and recovery of related illegal fees due to the exchange of daily necessities for drug settlements [1][3]. Group 1: Violation Details - Two branches of Inner Mongolia Renhe Tang Pharmaceutical Chain Co., Ltd. were found to have engaged in the practice of exchanging daily necessities for drug settlements, resulting in the termination of their medical insurance agreements and the recovery of illegal fees [1][3]. - The medical security bureau acted on complaints from the public and conducted investigations, confirming the violations at the 161st and 162nd branches of the company [3]. - The company has a history of violations, with previous branches (157th and 158th) reported for similar issues last year, leading to the termination of their medical insurance agreements and a one-year ban on applying for medical insurance designation [3]. Group 2: Company Background - Inner Mongolia Renhe Tang Pharmaceutical Chain Co., Ltd. was established in 2003 and is a national pharmaceutical chain with nearly 1,500 direct stores [4][5]. - The company is primarily owned by Linyi Renhe Tang Pharmaceutical (Chain) Co., Ltd., which holds 85.44% of the shares, and is ultimately controlled by Xiangyu Industrial Group Co., Ltd. [4]. - The company has been recognized for six consecutive years as one of the "Top 100 Direct Chain Pharmacies in China" and "Top 100 Comprehensive Competitiveness Chain Pharmacies in China" [5].